Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, February 11 '25)

Image
By G.M.

 


    Ann Intern Med

  1. IOANNOU GN, Berry K, Rajeevan N, Li Y, et al
    Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up : A Target Trial Emulation.
    Ann Intern Med. 2025 Feb 4. doi: 10.7326/ANNALS-24-01015.
    PubMed         Abstract available


    Antiviral Res

  2. UEHARA T, Yotsuyanagi H, Ohmagari N, Doi Y, et al
    Ensitrelvir treatment-emergent amino acid substitutions in SARS-CoV-2 3CL(pro) detected in the SCORPIO-SR phase 3 trial.
    Antiviral Res. 2025 Jan 30:106097. doi: 10.1016/j.antiviral.2025.106097.
    PubMed         Abstract available


    Clin Infect Dis

  3. SMITH EA, Javier GM, Multani A, Beaird OE, et al
    Anti-SARS-CoV-2 IgG Antibody Titers in Cotemporary lots of Intravenous Immune Globulin and Fresh Frozen Plasma Compared to COVID Convalescent Plasma.
    Clin Infect Dis. 2025 Feb 3:ciaf045. doi: 10.1093.
    PubMed         Abstract available

  4. REGAN AK, Rowe SL, Sullivan SG, Coates MM, et al
    Coronavirus Disease 2019 Antiviral Medication Use Among Pregnant and Recently Pregnant US Outpatients.
    Clin Infect Dis. 2025 Feb 5:ciae580. doi: 10.1093.
    PubMed         Abstract available

  5. MANDEL H, Yoo YJ, Allen AJ, Abedian S, et al
    Long-COVID incidence proportion in adults and children between 2020 and 2024.
    Clin Infect Dis. 2025 Feb 5:ciaf046. doi: 10.1093.
    PubMed         Abstract available


    J Infect

  6. QUINT JK, Dube S, Carty L, Yokota R, et al
    Immunocompromised individuals remain at risk of COVID-19: 2023 results from the observational INFORM study.
    J Infect. 2025 Jan 29:106432. doi: 10.1016/j.jinf.2025.106432.
    PubMed         Abstract available


    J Med Virol

  7. ZODDA E, Pons M, DeMoya-Valenzuela N, Calvo-Gonzalez C, et al
    Induction of the Inflammasome by the SARS-CoV-2 Accessory Protein ORF9b, Abrogated by Small-Molecule ORF9b Homodimerization Inhibitors.
    J Med Virol. 2025;97:e70145.
    PubMed         Abstract available

  8. CHANG S, Shin J, Park S, Park H, et al
    Continuous Tracking for Effective Tackling: Ad5/35 Platform-Based JN1 Lineage Vaccines Development in Response to Evolving SARS-CoV-2 Variants.
    J Med Virol. 2025;97:e70206.
    PubMed         Abstract available

  9. SUN J, Cheng J, Shi D, Xu X, et al
    Genetic Epidemiology of Porcine Epidemic Diarrhea Virus Circulating in China From 2010 to 2024: Characterization of Phylogenetic and Genetic Diversity of S1-Based Genes.
    J Med Virol. 2025;97:e70198.
    PubMed         Abstract available

  10. PENG Y, Zhang Y, Zeng S, Cai C, et al
    A Comprehensive Pan-Cancer Analysis of COVID-19 Booster Vaccination Efficacy and Safety.
    J Med Virol. 2025;97:e70211.
    PubMed        


    J Virol

  11. KUHN AJ, Outlaw VK, Marcink TC, Yu Z, et al
    Enhancing the solubility of SARS-CoV-2 inhibitors to increase future prospects for clinical development.
    J Virol. 2025 Feb 4:e0215924. doi: 10.1128/jvi.02159.
    PubMed         Abstract available

  12. PARK H, Kingstad-Bakke B, Cleven T, Jung M, et al
    Diversifying T-cell responses: safeguarding against pandemic influenza with mosaic nucleoprotein.
    J Virol. 2025 Feb 3:e0086724. doi: 10.1128/jvi.00867.
    PubMed         Abstract available

  13. WANG X, Dong M, Wu X, Schnepf D, et al
    Single-cell transcriptomics reveals a compartmentalized antiviral interferon response in the nasal epithelium of mice.
    J Virol. 2025 Feb 4:e0141324. doi: 10.1128/jvi.01413.
    PubMed         Abstract available

  14. PHAN T, Ribeiro RM, Edelstein GE, Boucau J, et al
    Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance.
    J Virol. 2025 Feb 4:e0162324. doi: 10.1128/jvi.01623.
    PubMed         Abstract available


    Lancet Infect Dis

  15. WANG Q, Mellis IA, Wu M, Bowen A, et al
    KP.2-based monovalent mRNA vaccines robustly boost antibody responses to SARS-CoV-2.
    Lancet Infect Dis. 2025 Feb 4:S1473-3099(25)00058.
    PubMed        

  16. SUTHAR MS, Manning KE, Ellis ML, Jain S, et al
    The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant.
    Lancet Infect Dis. 2025 Jan 31:S1473-3099(25)00007.
    PubMed        

  17. XIE Y
    COVID-19 versus influenza: the need to align policies with COVID-19 realities.
    Lancet Infect Dis. 2025 Jan 29:S1473-3099(25)00001.
    PubMed        

  18. BAGER P, Svalgaard IB, Lomholt FK, Emborg HD, et al
    The hospital and mortality burden of COVID-19 compared with influenza in Denmark: a national observational cohort study, 2022-24.
    Lancet Infect Dis. 2025 Jan 29:S1473-3099(24)00806.
    PubMed         Abstract available

  19. LIU J, Yu Y, Yang S, Jian F, et al
    Virological and antigenic characteristics of SARS-CoV-2 variants LF.7.2.1, NP.1, and LP.8.1.
    Lancet Infect Dis. 2025 Jan 28:S1473-3099(25)00015.
    PubMed        


    Nature

  20. LEDFORD H
    Four lessons COVID taught us about the immune system.
    Nature. 2025;638:19-20.
    PubMed        

  21. LEE S, Yu Y, Trimpert J, Benthani F, et al
    Author Correction: Virus-induced senescence is a driver and therapeutic target in COVID-19.
    Nature. 2025 Feb 4. doi: 10.1038/s41586-025-08718.
    PubMed        

  22. CHEMAITELLY H, Ayoub HH, Coyle P, Tang P, et al
    Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron.
    Nature. 2025 Feb 5. doi: 10.1038/s41586-024-08511.
    PubMed         Abstract available


    Radiology

  23. WEIR-MCCALL JR, Bell JS
    COVID-19 Infection and Coronary Plaque Progression: An Early Warning of a Potential Public Health Crisis.
    Radiology. 2025;314:e243767.
    PubMed        

  24. DAI N, Tang X, Hu Y, Lu H, et al
    SARS-CoV-2 Infection Association with Atherosclerotic Plaque Progression at Coronary CT Angiography and Adverse Cardiovascular Events.
    Radiology. 2025;314:e240876.
    PubMed         Abstract available


    Science

  25. GOSTIN LO, Meier BM
    A world less safe and secure.
    Science. 2025;387:559.
    PubMed         Abstract available


    Travel Med Infect Dis

  26. PLAZA PI, Lambertucci SA
    Differences between Influenza H5N1, A/H1N1 2009, and SARS-CoV-2 in a pandemic risk scenario.
    Travel Med Infect Dis. 2025 Jan 31:102811. doi: 10.1016/j.tmaid.2025.102811.
    PubMed        


    Zhonghua Jie He He Hu Xi Za Zhi

  27. WANG T, Chen X, Shi XP, He YX, et al
    [COVID-19 infection with tracheobronchomalacia: a case report].
    Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:138-141.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#USA, APHIS Confirms {Avian #Influenza #H5N1} #D11 #Genotype in Dairy #Cattle in #Nevada

By G.M.
On January 31, 2025, the USDA Animal and Plant Health Inspection Service (APHIS) National Veterinary Services Laboratories (NVSL) confirmed by whole genome sequence the first detection of highly pathogenic avian influenza (HPAI) H5N1 clade 2.3.4.4b, genotype D1.1 in dairy cattle .  This confirmation was a result of State tracing and investigation, following an initial detection on silo testing under the USDA’s National Milk Testing Strategy (NMTS) in Nevada.  USDA APHIS continues to work with the Nevada Department of Agriculture by conducting additional on-farm investigation, testing, and gathering additional epidemiological information to better understand this detection and limit further disease spread.  This is the first detection of this virus genotype in dairy cattle (all previous detections in dairy cattle have been HPAI H5N1 clade 2.3.4.4b, genotype B3.13 ).  Genotype D1.1 represents the predominant genotype in the North American flyways this past fall an...
Post a Comment
Read more »

#USA, After #Birdflu Detected in Local #Cat, County #Health Officials Say #Pet Owners Should Contact Veterinarian When Their Pets are Sick

By G.M.
Redwood City — State veterinary and health officials have confirmed a case of H5N1 (bird flu) in a domestic stray cat in San Mateo County.  The infection, which is not related to the recent instance of bird flu in a backyard flock , was found in a stray cat in Half Moon Bay that had been taken in by a family .  When it showed symptoms, they took it to Peninsula Humane Society, whose veterinarians examined it and requested testing. Lab results confirmed H5N1.  It is not known how the cat was infected and it was euthanized due to its condition. Cats may be exposed to bird flu by consuming infected bird , being in environments contaminated with the virus and consuming unpasteurized milk from infected cows or raw food. Inside domestic animals, such as cats and dogs, that go outside are also at risk of infection.​​​​​​​ According to the Centers for Disease Control and Prevention, the risk of cats spreading H5N1 to people is extremely low, though it is possible for cats to spre...
Post a Comment
Read more »

#USA, Novel #Influenza A #H5N1 Virus: One Pediatric Case in #California {FluView}

By G.M.
 {Excerpt} One confirmed human infection with influenza A(H5) virus was reported to CDC this week. To date, human-to-human transmission of influenza A(H5) virus has not been identified in the United States. This case was reported by the California Department of Public Health and occurred in a child less than 18 years old with no known contact with influenza A(H5N1) virus-infected animals or humans . The investigation into the source of infection for this case is ongoing , and no human-to-human transmission has been identified. A specimen from the individual was tested at a public health laboratory using the CDC influenza A(H5) assay before being sent to CDC for further testing. The specimen was positive for influenza A(H5) virus using diagnostic RT-PCR at CDC. Additional analysis including genetic sequencing is underway. In response to this detection, additional case investigation and contact monitoring are being conducted by public health officials in California. There have now be...
Post a Comment
Read more »